IS3378A7 - 1,4 - Dihydropyridines, og aðferð við framleiðslu þess svo og notkun þess í lækningaskyni - Google Patents

1,4 - Dihydropyridines, og aðferð við framleiðslu þess svo og notkun þess í lækningaskyni

Info

Publication number: IS3378A7
Authority: IS; Iceland
Prior art keywords: methyl; dihydropyridines; manufacture; well; therapeutic use
Prior art date: 1987-08-03

Application number

IS3378A

Other languages

English (en)

Other versions

IS1549B (is

Inventor

Fernandez Torija Carlos

Alvaro Galiano Ramos Joaquin

Original Assignee

Almirall-Prodesfarma, S.A.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1987-08-03

Filing date

1988-08-02

Publication date

1989-02-04

1988-08-02 Application filed by Almirall-Prodesfarma, S.A. filed Critical Almirall-Prodesfarma, S.A.

1989-02-04 Publication of IS3378A7 publication Critical patent/IS3378A7/is

1994-06-08 Publication of IS1549B publication Critical patent/IS1549B/is

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
- C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Heart & Thoracic Surgery (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Cardiology (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Urology & Nephrology (AREA)
Vascular Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Hydrogenated Pyridines (AREA)
Plural Heterocyclic Compounds (AREA)
Pyridine Compounds (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

IS3378A 1987-08-03 1988-08-02 1,4 - Dihydropyridines, og aðferð við framleiðsluþess svo og notkun þess í lækningaskyni IS1549B (is)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
EP87401799A EP0302980B1 (fr)	1987-08-03	1987-08-03	1,4-Dihydropyridines, leur procédé de préparation et leur application comme médicaments

Publications (2)

Publication Number	Publication Date
IS3378A7 true IS3378A7 (is)	1989-02-04
IS1549B IS1549B (is)	1994-06-08

Family

ID=8198243

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IS3378A IS1549B (is)	1987-08-03	1988-08-02	1,4 - Dihydropyridines, og aðferð við framleiðsluþess svo og notkun þess í lækningaskyni

Country Status (34)

Country	Link
US (1)	US4952592A (is)
EP (1)	EP0302980B1 (is)
JP (1)	JPH0733383B2 (is)
KR (1)	KR960001724B1 (is)
CN (1)	CN1038587C (is)
AT (1)	ATE61588T1 (is)
BE (1)	BE1001055A4 (is)
CA (2)	CA1306261C (is)
CH (1)	CH675999A5 (is)
CZ (1)	CZ282077B6 (is)
DD (1)	DD282008A5 (is)
DE (2)	DE3768658D1 (is)
DK (1)	DK430288A (is)
ES (1)	ES2007543A6 (is)
FI (1)	FI91406C (is)
GB (1)	GB2208861B (is)
GR (2)	GR880100507A (is)
HU (1)	HU204523B (is)
IE (1)	IE60358B1 (is)
IL (1)	IL87321A (is)
IN (1)	IN167550B (is)
IS (1)	IS1549B (is)
IT (1)	IT1235013B (is)
LU (1)	LU87297A1 (is)
MA (1)	MA21344A1 (is)
NO (1)	NO170934C (is)
NZ (1)	NZ225661A (is)
PH (1)	PH25645A (is)
PT (1)	PT88173B (is)
RU (1)	RU2036922C1 (is)
SK (1)	SK541388A3 (is)
TN (1)	TNSN88081A1 (is)
YU (1)	YU46547B (is)
ZA (1)	ZA885684B (is)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5242933A (en) *	1990-07-10	1993-09-07	Adir Et Compagnie	Piperidine, tetrahydropyridine and pyrrolidine compounds
EP0854721B1 (en) *	1995-08-02	2001-10-24	Smithkline Beecham Corporation	Endothelin receptor antagonists
DE60128683T2 (de) *	2000-04-11	2008-01-24	Sankyo Co., Ltd.	Stabilisierte pharmazeutische zusammenstellungen die den calziumkanalblocker azelnidipine enthalten
OA12905A (en)	2002-08-19	2006-10-13	Pfizer Prod Inc	Combination therapy for hyperproliferative diseases.
MX2007000979A (es) *	2004-07-26	2007-07-11	Cotherix Inc	Tratamiento de la hipertension pulmonar por iloprost inhalado con una formulacion microparticulada.
US7741317B2 (en)	2005-10-21	2010-06-22	Bristol-Myers Squibb Company	LXR modulators
WO2007050783A2 (en)	2005-10-26	2007-05-03	Asahi Kasei Pharma Corporation	Fasudil in combination therapies for the treatment of pulmonary arterial hypertension
EP2351569B1 (en)	2005-10-26	2012-08-22	Asahi Kasei Pharma Corporation	Fasudil in combination therapies for the treatment of pulmonary arterial hypertension
US7888376B2 (en)	2005-11-23	2011-02-15	Bristol-Myers Squibb Company	Heterocyclic CETP inhibitors
TW200736245A (en) *	2005-11-29	2007-10-01	Sankyo Co	Acid addition salts of optically active dihydropyridine derivatives
TW200806648A (en) *	2005-11-29	2008-02-01	Sankyo Co	Acid addition salts of dihydropyridine derivatives
US7919506B2 (en)	2006-03-10	2011-04-05	Pfizer Inc.	Dibenzyl amine compounds and derivatives
WO2008070496A2 (en)	2006-12-01	2008-06-12	Bristol-Myers Squibb Company	N- ( (3-benzyl) -2, 2- (bis-phenyl) -propan-1-amine derivatives as cetp inhibitors for the treatment of atherosclerosis and cardiovascular diseases
WO2012037665A1 (en)	2010-09-24	2012-03-29	Oral Delivery Technology Ltd.	Nitric oxide releasing amino acid ester for treatment of pulmonary hypertension and other respiratory conditions
RU2618628C1 (ru)	2013-04-17	2017-05-05	Пфайзер Инк.	Производные N-пиперидин-3-илбензамида для лечения сердечно-сосудистых заболеваний
WO2016055901A1 (en)	2014-10-08	2016-04-14	Pfizer Inc.	Substituted amide compounds
CA3125765A1 (en)	2019-01-18	2020-07-23	Astrazeneca Ab	Pcsk9 inhibitors and methods of use thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3441648A (en) *	1967-02-07	1969-04-29	Smithkline Corp	Compositions and methods for lowering blood pressure with 1,4-dihydropyridines
US4031104A (en) *	1972-04-18	1977-06-21	Bayer Aktiengesellschaft	1,4-Dihydropyridine carboxylic acid esters
JPS5978186A (ja) *	1982-10-27	1984-05-04	Yoshitomi Pharmaceut Ind Ltd	１，４−ジヒドロピリジン−３，５−ジカルボン酸エステル誘導体
ES8507495A1 (es) *	1984-03-27	1985-09-01	Inst Investigacion Desarrollo	Un procedimiento para la preparacion de nuevas 1,4-dihidropirinas-4-(polioxialquilfenil)-sustituidas
IE57810B1 (en) *	1984-03-27	1993-04-21	Delagrange Lab	1,4-dihydropyridine derivatives,their preparation and their use
JPH068294B2 (ja) *	1985-02-26	1994-02-02	富山化学工業株式会社	新規な１，４−ジヒドロピリジン誘導体およびその塩
EP0174131A3 (en) *	1984-09-01	1989-06-07	FISONS plc	Dihydropyridines, processes and intermediates for their production, and pharmaceutical formulations containing them
JPH01207267A (ja) *	1987-03-05	1989-08-21	Yamanouchi Pharmaceut Co Ltd	ピリジン誘導体及び該化合物を含有する肝疾患治療剤

1987
- 1987-08-03 AT AT87401799T patent/ATE61588T1/de active
- 1987-08-03 DE DE8787401799T patent/DE3768658D1/de not_active Expired - Lifetime
- 1987-08-03 EP EP87401799A patent/EP0302980B1/fr not_active Expired - Lifetime
1988
- 1988-07-27 LU LU87297A patent/LU87297A1/fr unknown
- 1988-07-29 CA CA000573422A patent/CA1306261C/fr not_active Expired - Lifetime
- 1988-07-29 YU YU147088A patent/YU46547B/sh unknown
- 1988-07-29 DE DE3825962A patent/DE3825962A1/de not_active Withdrawn
- 1988-08-01 FI FI883603A patent/FI91406C/fi not_active IP Right Cessation
- 1988-08-01 NO NO883406A patent/NO170934C/no unknown
- 1988-08-01 DD DD88318537A patent/DD282008A5/de not_active IP Right Cessation
- 1988-08-01 JP JP63192591A patent/JPH0733383B2/ja not_active Expired - Lifetime
- 1988-08-01 MA MA21587A patent/MA21344A1/fr unknown
- 1988-08-02 PT PT88173A patent/PT88173B/pt not_active IP Right Cessation
- 1988-08-02 SK SK5413-88A patent/SK541388A3/sk unknown
- 1988-08-02 NZ NZ225661A patent/NZ225661A/xx unknown
- 1988-08-02 DK DK430288A patent/DK430288A/da not_active Application Discontinuation
- 1988-08-02 IL IL87321A patent/IL87321A/xx not_active IP Right Cessation
- 1988-08-02 CH CH2922/88A patent/CH675999A5/fr not_active IP Right Cessation
- 1988-08-02 IT IT8848259A patent/IT1235013B/it active
- 1988-08-02 BE BE8800893A patent/BE1001055A4/fr not_active IP Right Cessation
- 1988-08-02 GR GR880100507A patent/GR880100507A/el unknown
- 1988-08-02 US US07/227,373 patent/US4952592A/en not_active Expired - Fee Related
- 1988-08-02 KR KR1019880009867A patent/KR960001724B1/ko not_active IP Right Cessation
- 1988-08-02 HU HU884065A patent/HU204523B/hu not_active IP Right Cessation
- 1988-08-02 ES ES8802413A patent/ES2007543A6/es not_active Expired
- 1988-08-02 IS IS3378A patent/IS1549B/is unknown
- 1988-08-02 CZ CS885413A patent/CZ282077B6/cs not_active IP Right Cessation
- 1988-08-02 GB GB8818356A patent/GB2208861B/en not_active Expired - Lifetime
- 1988-08-02 IE IE236488A patent/IE60358B1/en not_active IP Right Cessation
- 1988-08-02 CN CN88106537A patent/CN1038587C/zh not_active Expired - Fee Related
- 1988-08-02 TN TNTNSN88081A patent/TNSN88081A1/fr unknown
- 1988-08-03 PH PH37337A patent/PH25645A/en unknown
- 1988-08-03 IN IN556/MAS/88A patent/IN167550B/en unknown
- 1988-08-03 ZA ZA885684A patent/ZA885684B/xx unknown
1990
- 1990-08-28 CA CA000615848A patent/CA1306262C/fr not_active Expired - Lifetime
1991
- 1991-05-22 GR GR91400660T patent/GR3001984T3/el unknown
1992
- 1992-03-31 RU SU925011204A patent/RU2036922C1/ru active

Also Published As

Publication number	Publication date
MA21344A1 (fr)	1989-04-01
KR960001724B1 (ko)	1996-02-03
DE3825962A1 (de)	1989-02-16
TNSN88081A1 (fr)	1990-07-10
IE882364L (en)	1989-02-03
US4952592A (en)	1990-08-28
HUT54142A (en)	1991-01-28
IS1549B (is)	1994-06-08
DE3768658D1 (de)	1991-04-18
LU87297A1 (fr)	1989-02-02
NO170934B (no)	1992-09-21
SK278775B6 (sk)	1998-02-04
SK541388A3 (en)	1998-02-04
ATE61588T1 (de)	1991-03-15
FI91406C (fi)	1994-06-27
NZ225661A (en)	1990-08-28
IL87321A0 (en)	1989-01-31
HU204523B (en)	1992-01-28
RU2036922C1 (ru)	1995-06-09
PT88173A (pt)	1989-06-30
CZ541388A3 (en)	1997-01-15
IE60358B1 (en)	1994-06-29
JPH0733383B2 (ja)	1995-04-12
EP0302980B1 (fr)	1991-03-13
NO883406L (no)	1989-02-06
AU2033088A (en)	1989-02-09
CN1031531A (zh)	1989-03-08
DK430288D0 (da)	1988-08-02
PT88173B (pt)	1995-03-01
PH25645A (en)	1991-08-21
FI883603A0 (fi)	1988-08-01
IT1235013B (it)	1992-06-16
FI883603A (fi)	1989-02-04
JPH01294675A (ja)	1989-11-28
FI91406B (fi)	1994-03-15
GR3001984T3 (en)	1992-11-23
CZ282077B6 (cs)	1997-05-14
YU147088A (en)	1990-04-30
KR890003743A (ko)	1989-04-17
CA1306261C (fr)	1992-08-11
IT8848259A0 (it)	1988-08-02
BE1001055A4 (fr)	1989-06-20
CN1038587C (zh)	1998-06-03
AU606441B2 (en)	1991-02-07
CH675999A5 (en)	1990-11-30
YU46547B (sh)	1993-11-16
NO170934C (no)	1992-12-30
ES2007543A6 (es)	1989-06-16
DK430288A (da)	1989-02-03
NO883406D0 (no)	1988-08-01
GR880100507A (el)	1989-05-25
IL87321A (en)	1993-04-04
GB8818356D0 (en)	1988-09-07
IN167550B (is)	1990-11-10
DD282008A5 (de)	1990-08-29
ZA885684B (en)	1989-04-26
CA1306262C (fr)	1992-08-11
EP0302980A1 (fr)	1989-02-15
GB2208861A (en)	1989-04-19
GB2208861B (en)	1991-07-17

Publication	Publication Date	Title
IS3378A7 (is)	1989-02-04	1,4 - Dihydropyridines, og aðferð við framleiðslu þess svo og notkun þess í lækningaskyni
EA199700209A1 (ru)	1998-04-30	ПРОИЗВОДНЫЕ ИМИДАЗО[1,2-a]ПИРИДИНА
NO963506L (no)	1996-10-22	4-Heterocyklyl-substituerte kinazolin-derivater, fremgangsmåte for fremstilling derav og deres anvendelse som anti-kreftmidler
FI900307A0 (fi)	1990-01-19	Menetelmä valmistaa terapeuttisesti aktiivista 3-/3-okso-(2,3)-dihydropyridatsin-6-yyli/-2-fenyyli-pyratsolo/1,5-a/pyridiinijohdannaisia
DK84088A (da)	1988-08-21	Naphthalenderivater med anvendelse som antiallergiske og antiinflammatoriske midler
HUT47580A (en)	1989-03-28	Process for production of tricycle oxindole derivatives decreasing inflammation
FR2570701B1 (fr)	1987-05-22	Derives de furo(3,2-c)pyridines, leur preparation et leur application en therapeutique
FI99013B (fi)	1997-06-13	Analogiamenetelmä terapeuttisesti käyttökelpoisten bentsimidatsolijohdannaisten valmistamiseksi
DE3566263D1 (de)	1988-12-22	Novel cyanoimidazole nucleoside derivatives
FI810103L (fi)	1981-07-17	Nya 2,3-dihydro-imidazo /1,2-b/ pyridazinderivat foerfarande foer deras framstaellning och deras terapeutiska anvaendning
SE8605255L (sv)	1987-06-10	4h-benso(4,5)cyklohepta(1,2-b)tiofen-derivat
NO176277C (no)	1995-03-08	Analogifremgangsmåte for fremstilling av terapeutisk aktive 3,4-dihydro-2-alkyl-3-okso-N-aryl-2H-[1Åbenzotieno[3,2-eÅ-1,2-tiazin-4-karboksamid-1,1-dioksyder
HUT45255A (en)	1988-06-28	Process for producing furo/3,4-b/pyridine derivatives and pharmaceutical compositions comprising these compounds
PL293117A1 (en)	1992-12-28	Method of obtaining substituted alkenic acid and its derivatives
PT83883A (en)	1987-01-01	Process for the preparation of 4h-benzo]4,5"cyclohepta]1,2-b"thiophene derivatives
PT79509A (en)	1984-12-01	Method for preparing diphenylsulfide derivatives